Abstract
CMV infection remains a cause of death in heart transplantation (HT). IgG hypogammaglobulinemia is a risk factor of this complication. We assessed IgG immune reconstitution after inespecific intravenous immunoglobulin (IVIG) replacement therapy for secondary IgG hypogammaglobulinemia (HGG) in heart recipients with post-transplant CMV infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
